{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52026614",
    "licUnit": "1",
    "validDate": "2025-09-01 00:00:00.000",
    "issueDate": "2015-09-01 00:00:00.000",
    "oriIssueDate": "2015-09-01",
    "licKind": "02",
    "oldLicid": null,
    "certNo": "DHA05202661401",
    "prodNameC": "艾亭寧膜衣錠400毫克",
    "prodNameE": "Alvotinib 400mg Film-Coated tablets",
    "indicationsName": [
        "治療正值急性轉化期（BLAST CRISIS）、加速期或經ALPHA-干擾素治療無效之慢性期的慢性骨髓性白血病（CML）患者。治療成年人無法手術切除或轉移的惡性胃腸道基質瘤。用於治療初診斷慢性骨髓性白血病（CML）的病人。治療初診斷為費城染色體陽性急性淋巴性白血病（Ph+ALL）且併用化療之成年及兒童患者。做為治療成人復發性或難治性費城染色體陽性急性淋巴性白血病（Ph+ALL）之單一療法。治療患有與血小板衍生生長因子體（PDGFR）基因重組相關之骨髓發育不全症候群（MDS）／骨髓增生性疾病（MPD）之成人患者。治療患有系統性肥大細胞增生症（SM），限具FIP1L1-PDGFR基因變異且不具有c-Kit基因D816V突變之成人患者。治療嗜伊紅性白血球增加症候群（HES）與／或慢性嗜伊紅性白血病（CEL）且有血小板衍生生長因子受體（PDGFR）基因重組之成人患者。作為成人KIT（CD 117）陽性胃腸道基質瘤完全切除後（complete gross resection）之術後輔助治療。治療無法手術切除、復發性或轉移性且有血小板衍生生長因子受體（PDGFR）基因重組之隆突性皮膚纖維肉瘤（DFSP）之成人患者。"
    ],
    "does": "1116",
    "packageUnit": [
        {
            "packageSpec": "2-1000錠",
            "packageUnit": "8S"
        }
    ],
    "medMCode": "06",
    "maMedCode": "",
    "medDCode": null,
    "mainCategory": null,
    "drBaseId": "6BB489C4-7F76-474D-920B-905C61A43566",
    "subCategory": [],
    "ingredientsDesc": [
        "IMATINIB MESYLATE"
    ],
    "restraintItemsCode": [
        "02 輸 入",
        "24 監視期滿學名藥"
    ],
    "applicantName": "美時化學製藥股份有限公司",
    "applicantAddr": "台北市信義區松仁路277號17樓",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": null,
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "1556397E-9F56-42C4-B4A1-1EA547681A19",
            "factoryCode": "1",
            "factoryName": "REMEDICA LTD. ",
            "factoryAddr": "AHARNON STREET, LIMASSOL INDUSTRIAL ESTATE , LIMASSOL 3056, CYPRUS ",
            "factoryCompanyAddr": null,
            "countryCode": "CY",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FCY0005100",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        },
        {
            "id": "51092C2E-ED4D-4771-967A-715EC980639A",
            "factoryCode": "2",
            "factoryName": "美時化學製藥股份有限公司南投廠",
            "factoryAddr": "南投縣南投市新興里成功一路３０號",
            "factoryCompanyAddr": null,
            "countryCode": "TW",
            "processCode": [
                {
                    "value": "02",
                    "name": "包裝"
                }
            ],
            "processCodeStr": "02;包裝",
            "factoryKind": "M",
            "factoryNo": "0901314300",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": "1013000710",
            "ingredientsName": "IMATINIB MESYLATE",
            "ingredientsDesc": "IMATINIB MESYLATE",
            "concentDesc": "(Equivalent to Imatinib 400mg)",
            "concent": "478.000000",
            "concentUnit": "001",
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "1"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "L01EA01"
        }
    ],
    "licBaseId": "8EE20FDA-1094-4CC9-9757-A181A54CFE66"
}